AT303953B - Verfahren zur Herstellung eines Mittels zur Hemmung der Chlorwasserstoffsekretion des Magens - Google Patents

Verfahren zur Herstellung eines Mittels zur Hemmung der Chlorwasserstoffsekretion des Magens

Info

Publication number
AT303953B
AT303953B AT384671A AT384671A AT303953B AT 303953 B AT303953 B AT 303953B AT 384671 A AT384671 A AT 384671A AT 384671 A AT384671 A AT 384671A AT 303953 B AT303953 B AT 303953B
Authority
AT
Austria
Prior art keywords
manufacture
agent
hydrogen chloride
inhibiting gastric
chloride secretion
Prior art date
Application number
AT384671A
Other languages
English (en)
Original Assignee
Haessle Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Haessle Ab filed Critical Haessle Ab
Application granted granted Critical
Publication of AT303953B publication Critical patent/AT303953B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
AT384671A 1969-12-09 1970-11-27 Verfahren zur Herstellung eines Mittels zur Hemmung der Chlorwasserstoffsekretion des Magens AT303953B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6012969 1969-12-09

Publications (1)

Publication Number Publication Date
AT303953B true AT303953B (de) 1972-12-27

Family

ID=10485066

Family Applications (3)

Application Number Title Priority Date Filing Date
AT384571A AT299234B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung von neuen Carbaminsäureestern
AT384671A AT303953B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung eines Mittels zur Hemmung der Chlorwasserstoffsekretion des Magens
AT1069670A AT299233B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung von neuen Carbaminsäureestern

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT384571A AT299234B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung von neuen Carbaminsäureestern

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT1069670A AT299233B (de) 1969-12-09 1970-11-27 Verfahren zur Herstellung von neuen Carbaminsäureestern

Country Status (7)

Country Link
AT (3) AT299234B (de)
AU (1) AU2222570A (de)
BE (1) BE758427A (de)
DE (2) DE2062374A1 (de)
FR (1) FR2081335A1 (de)
NL (1) NL7017727A (de)
ZA (1) ZA707100B (de)

Also Published As

Publication number Publication date
AT299233B (de) 1972-06-12
AT299234B (de) 1972-06-12
DE2062374A1 (de) 1971-06-24
BE758427A (fr) 1971-04-16
AU2222570A (en) 1972-05-18
ZA707100B (en) 1971-07-28
FR2081335A1 (en) 1971-12-03
NL7017727A (de) 1971-06-11
DE2054124A1 (de) 1971-06-24

Similar Documents

Publication Publication Date Title
CH436731A (de) Verfahren zur Herstellung eines Organosiloxanblockmischpolymerisates
CH544129A (de) Verfahren zur Herstellung von geschäumten Polyurethanen
AT322400B (de) Verfahren zur herstellung eines schleifkoerpers
AT300344B (de) Verfahren zur Herstellung eines Mischpolymerisates
AT258770B (de) Verfahren zur Herstellung eines elastischen Schichtenskis
CH505623A (de) Verfahren zur Herstellung eines Reinigungsmittels für Zahnprothesen
AT300371B (de) Verfahren zur Herstellung von Polyurethanen
AT293983B (de) Verfahren zur Herstellung eines Enzym-Träger-Systems
AT289790B (de) Verfahren zur Herstellung von 2-Mercapto-benzthiazol
CH422731A (de) Verfahren zur Herstellung von Chlorwasserstoff
AT297568B (de) Verfahren zur Herstellung eines wasserdurchlässigen Porbetons
AT296942B (de) Verfahren zur Herstellung von Acetylen
AT314395B (de) Verfahren zur Herstellung eines Effektgarns
CH532584A (de) Verfahren zur Herstellung substituierter N-Cycloalkylarylamino-imidazoline-(2)
AT321230B (de) Verfahren zur Herstellung eines Enzym-Tannin-Adduktes
CH535544A (de) Verfahren zur Herstellung eines streichfähigen Brotaufstrichs
AT317435B (de) Verfahren zur Herstellung eines antiseborrhoisch wirksamen Mittels
AT303953B (de) Verfahren zur Herstellung eines Mittels zur Hemmung der Chlorwasserstoffsekretion des Magens
AT319170B (de) Verfahren zur Herstellung eines Amylaseinhibitors
CH515783A (de) Verfahren zur Herstellung hygienisch-sanitärer Geräte
CH523307A (de) Verfahren zur Herstellung der B-Kristallmodifikation des linearen trans-Chinacridons
AT294842B (de) Verfahren zur Herstellung des Chinoxalin-di-N-oxyd-aldehyds
AT297658B (de) Verfahren zur Herstellung von Wasserstoff
CH537945A (de) Verfahren zur Herstellung kristalliner Solvate des Cephaloridins
AT299139B (de) Verfahren zur Herstellung primärer Alkenole

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee